News – Page 533 – Endpoints News

Fake news? Narcan maker forced to refute licensing deal after wire service apparently duped by false announcement

4 years ago

Tarsus to raise $75.6M for repurposed dog drug that's headed to FDA after eye drop's PhIII win

4 years ago

Your guide to pharma Q1 numbers; Unpacking top 15 R&D giants; Secret PhIII failures; 'Weirdo science' and ...

4 years ago

Aduhelm struggles barely affected CEO Michel Vounatsos' $17.7M pay

4 years ago

AbbVie tosses its triplet therapy for cystic fibrosis, leaving Vertex to reign supreme

4 years ago

FDA approvals, Revlimid LOE and Opdivo's label expansion headline Bristol Myers' start to 2022

4 years ago

Under pressure? FDA pencils in June review dates for Pfizer, Moderna Covid vaccines for kids, plus Novavax EUA

4 years ago

Production halted at Korean pharma after regulators find unauthorized additives in 13 drugs

4 years ago

Roche releases more Evrysdi data leading up to FDA decision for very young infants with SMA

4 years ago

University of Oxford spinoff nets a nine-figure Series B, but it won't beeline toward the clinic

4 years ago

Vaccine sales are expected to fade after a Q1 pop at AstraZeneca, but a slate of successful franchises buoys forecast

4 years ago

Construction kicks off at BeiGene's next US manufacturing flagship

4 years ago

Changing of the guard: Health marketing agencies Syneos Health and Evoke Kyne promote new female chiefs

4 years ago

Despite bruising market, two biotechs price their IPOs while another launches its Nasdaq bid

4 years ago

FDA tells Praxis it can't move into the clinic just yet for a rare epilepsy drug

4 years ago

As its slide stretches into a second year, Zymeworks faces takeover bid

4 years ago

Exclusive: Centrexion's knee pain drug fails two PhIII studies, but ex-Pfizer CEO Kindler's biotech might still ask ...

4 years ago

Arie and Dan Belldegrun are building biotech campuses around the globe — with a newly raised $3B fund to keep the ...

4 years ago

AstraZeneca unveils plans for R&D center in Kendall Square — which will also be Alexion's new HQ

4 years ago

Five years into neoantigen work, cash-strapped Genocea lays off staff as it looks for 'strategic alternatives'

4 years ago

FDA lifts hold on Finch’s microbiome crapsule, as company looks to right ship

4 years ago

‘Natural evolution’: Carisma’s scientific co-founder moves into the CSO post; Vas Narasimhan enlists Ronny Gal ...

4 years ago

Gilead’s Covid-19 treatment Veklury props up first quarter gains amid $2.7B Trodelvy writedown

4 years ago

Bristol Myers celebrates a big win with FDA approval of $13B cardio drug mavacamten

4 years ago

First page Previous page 530 531 532533534 535 536 Next page Last page